Compounds > arginylproline
Page last updated: 2024-09-04

arginylproline and Non-alcoholic Fatty Liver Disease

arginylproline has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

*Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Banno, A; Kiriyama, K; Matsuba, S; Mijiti, M; Mori, R; Nagaoka, S; Nakashima, Y; Sutoh, K; Takeuchi, A; Ye, Y1

Other Studies

1 other study(ies) available for arginylproline and Non-alcoholic Fatty Liver Disease

ArticleYear
Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells.
    Bioscience, biotechnology, and biochemistry, 2023, Jan-24, Volume: 87, Issue:2

    Topics: Hep G2 Cells; Humans; Lipogenesis; Non-alcoholic Fatty Liver Disease; Oleic Acid; Peptide Transporter 1; Peptides; Proline; Protamines

2023